{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T02:17:42Z","timestamp":1792808262382,"version":"4.5.0"},"reference-count":33,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2020,10,13]],"date-time":"2020-10-13T00:00:00Z","timestamp":1602547200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"name":"Clinical and Translational Science Institute"},{"name":"David Scaife Family Charitable Foundation"},{"name":"Pediatric Infectious Disease Society"},{"DOI":"10.13039\/100009633","name":"Eunice Kennedy Shriver National Institute of Child Health and Human Development","doi-asserted-by":"publisher","award":["K12HD000850-34"],"award-info":[{"award-number":["K12HD000850-34"]}],"id":[{"id":"10.13039\/100009633","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Pediatric Scientist Development Program"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,4,30]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>The burden of coronavirus disease 2019 (COVID-19) is poorly understood in pediatric patients due to frequent asymptomatic and mild presentations. Additionally, the disease prevalence in pediatric immunocompromised patients remains unknown.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>This cross-sectional study tested convenience samples from pediatric patients who had clinically indicated lab work collected and an immunocompromising condition, including oncologic diagnoses, solid organ transplant (SOT), bone marrow transplant, primary immunodeficiency, and rheumatologic conditions or inflammatory bowel disease on systemic immunosuppression, for the presence of antibodies to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>We tested sera from 485 children and observed SARS-CoV-2 seroprevalence of 1.0% (Confidence Interval [CI] 95%: 0.3%\u20132.4%). Two patients were positive by nasopharyngeal (NP) swab Reverse transcriptase polymerase chain reaction (RT-PCR), but only 1 seroconverted. Patients with oncologic diagnoses or SOT were most likely to be tested for COVID-19 when presenting with respiratory illness as compared with other groups.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Seroprevalence of antibodies to SARS-CoV-2 in immunocompromised children was similar to that of an immunocompetent pediatric population (0.6%, CI 95%: 0.3%\u20131.1%), suggesting an adequate antibody response. However, none of the patients who tested positive for antibodies or via NP RT-PCR had more than a mild illness course and 2 patients did not have any reported illness, suggesting that SARS-CoV-2 may not cause a worse clinical outcome in immunosuppressed children, in contrast to immunocompromised adults.<\/jats:p><\/jats:sec>","DOI":"10.1093\/jpids\/piaa123","type":"journal-article","created":{"date-parts":[[2020,10,8]],"date-time":"2020-10-08T19:16:03Z","timestamp":1602184563000},"page":"426-431","source":"Crossref","is-referenced-by-count":18,"title":["Immunocompromised Seroprevalence and Course of Illness of SARS-CoV-2 in One Pediatric Quaternary Care Center"],"prefix":"10.1093","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3389-6731","authenticated-orcid":false,"given":"Megan Culler","family":"Freeman","sequence":"first","affiliation":[{"name":"Department of Pediatrics, Division of Infectious Diseases, UPMC Children\u2019s Hospital of Pittsburgh, Pittsburgh, Pennsylvania, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Glenn J","family":"Rapsinski","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Division of Infectious Diseases, UPMC Children\u2019s Hospital of Pittsburgh, Pittsburgh, Pennsylvania, USA"},{"name":"Department of Microbiology and Molecular Genetics, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan L","family":"Zilla","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7851-9836","authenticated-orcid":false,"given":"Sarah E","family":"Wheeler","sequence":"additional","affiliation":[{"name":"Department of Pathology, Division of Clinical Immunopathology and Clinical Chemistry, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA"},{"name":"Department of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2020,10,13]]},"reference":[{"key":"2021043017510027900_CIT0001","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1056\/NEJMoa2001017","article-title":"A novel coronavirus from patients with pneumonia in China, 2019","volume":"382","author":"Zhu","year":"2020","journal-title":"N Engl J Med"},{"key":"2021043017510027900_CIT0002","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1007\/s11606-020-05762-w","article-title":"Review of the clinical characteristics of coronavirus disease 2019 (COVID-19)","volume":"35","author":"Jiang","year":"2020","journal-title":"J Gen Intern Med"},{"key":"2021043017510027900_CIT0003","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/S0950-3536(05)80169-6","article-title":"Infections in the compromised child","volume":"4","author":"Viscoli","year":"1991","journal-title":"Baillieres Clin Haematol"},{"key":"2021043017510027900_CIT0004","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.1056\/NEJMra064928","article-title":"Infection in solid-organ transplant recipients","volume":"357","author":"Fishman","year":"2007","journal-title":"N Engl J Med"},{"key":"2021043017510027900_CIT0005","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1111\/1756-185X.12659","article-title":"Serious infection during etanercept, infliximab and adalimumab therapy for rheumatoid arthritis: a literature review","volume":"19","author":"Downey","year":"2016","journal-title":"Int J Rheum Dis"},{"key":"2021043017510027900_CIT0006","doi-asserted-by":"crossref","first-page":"e13407","DOI":"10.1111\/tid.13407","article-title":"COVID-19 in solid organ transplant recipients: dynamics of disease progression and inflammatory markers in ICU and non-ICU admitted patients","author":"Roberts","year":"2020","journal-title":"Transpl Infect Dis"},{"key":"2021043017510027900_CIT0007","doi-asserted-by":"crossref","first-page":"2933","DOI":"10.1111\/ajt.15993","article-title":"COVID-19 pneumonia in lung transplant recipients: report of 2 cases","volume":"20","author":"Cozzi","year":"2020","journal-title":"Am J Transplant"},{"key":"2021043017510027900_CIT0008","doi-asserted-by":"crossref","first-page":"e13377","DOI":"10.1111\/tid.13377","article-title":"SARS-CoV-2 infection in kidney transplant recipients: experience of the Italian Marche region","author":"Maritati","year":"2020","journal-title":"Transpl Infect Dis"},{"key":"2021043017510027900_CIT0009","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.1056\/NEJMc2011117","article-title":"Covid-19 and kidney transplantation","volume":"382","author":"Akalin","year":"2020","journal-title":"N Engl J Med"},{"key":"2021043017510027900_CIT0010","article-title":"COVID-19 in kidney transplant recipients: a multicenter experience in Istanbul","volume":"e13371","author":"Demir","year":"2020","journal-title":"Transpl Infect Dis"},{"key":"2021043017510027900_CIT0011","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/j.kint.2020.04.002","article-title":"A single center observational study of the clinical characteristics and short-term outcome of 20 kidney transplant patients admitted for SARS-CoV2 pneumonia","volume":"97","author":"Alberici","year":"2020","journal-title":"Kidney Int"},{"key":"2021043017510027900_CIT0012","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1111\/ajt.15891","article-title":"COVID-19 in kidney transplant recipients","volume":"20","author":"Gandolfini","year":"2020","journal-title":"Am J Transplant"},{"key":"2021043017510027900_CIT0013","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/j.annonc.2020.03.296","article-title":"Clinical characteristics of COVID-19-infected cancer patients: a retrospective case study in three hospitals within Wuhan, China","volume":"31","author":"Zhang","year":"2020","journal-title":"Ann Oncol"},{"key":"2021043017510027900_CIT0014","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S1470-2045(20)30096-6","article-title":"Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China","volume":"21","author":"Liang","year":"2020","journal-title":"Lancet Oncol"},{"key":"2021043017510027900_CIT0015","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1002\/jmv.25972","article-title":"Clinical characteristics and outcomes of cancer patients with COVID-19","volume":"92","author":"Yang","year":"2020","journal-title":"J Med Virol"},{"key":"2021043017510027900_CIT0016","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1158\/2159-8290.CD-20-0516","article-title":"Case fatality rate of cancer patients with COVID-19 in a New York hospital system","volume":"10","author":"Mehta","year":"2020","journal-title":"Cancer Discov"},{"key":"2021043017510027900_CIT0017","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1056\/NEJMc2009567","article-title":"Covid-19 in immune-mediated inflammatory diseases\u2014case series from New York","volume":"383","author":"Haberman","year":"2020","journal-title":"New Engl J Med"},{"key":"2021043017510027900_CIT0018","article-title":"SARS-CoV-2 serologic immune response in exogenously immunosuppressed patients. [Manuscript submitted for publication]","author":"Zilla","year":"2020"},{"key":"2021043017510027900_CIT0019","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/j.healun.2020.04.021","article-title":"COVID-19 in a pediatric heart transplant recipient: emergence of donor-specific antibodies","volume":"39","author":"Russell","year":"2020","journal-title":"J Heart Lung Transplant"},{"key":"2021043017510027900_CIT0020","article-title":"Varying presentations of COVID-19 in young heart transplant recipients: a case series","volume":"e13780","author":"Lee","year":"2020","journal-title":"Pediatr Transplant"},{"key":"2021043017510027900_CIT0021","doi-asserted-by":"crossref","first-page":"2942","DOI":"10.1111\/ajt.16003","article-title":"Mild COVID-19 in a pediatric renal transplant recipient","volume":"20","author":"Bush","year":"2020","journal-title":"Am J Transplant"},{"key":"2021043017510027900_CIT0022","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.arcped.2020.05.004","article-title":"Child with liver transplant recovers from COVID-19 infection. A case report","volume":"27","author":"Morand","year":"2020","journal-title":"Arch Pediatr"},{"key":"2021043017510027900_CIT0023","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ejca.2020.03.021","article-title":"Flash survey on severe acute respiratory syndrome coronavirus-2 infections in paediatric patients on anticancer treatment","volume":"132","author":"Hrusak","year":"2020","journal-title":"Eur J Cancer"},{"key":"2021043017510027900_CIT0024","doi-asserted-by":"crossref","DOI":"10.1093\/jpids\/piaa088","article-title":"Clinical characteristics and outcome of SARS-CoV-2 infection in Italian pediatric oncology patients: a study from the Infectious Diseases Working Group of the AIEOP","author":"Bisogno","year":"2020","journal-title":"J Pediatric Infect Dis Soc"},{"key":"2021043017510027900_CIT0025","doi-asserted-by":"crossref","first-page":"e28420","DOI":"10.1002\/pbc.28420","article-title":"COVID-19 disease in New York City pediatric hematology and oncology patients","volume":"67","author":"Gampel","year":"2020","journal-title":"Pediatr Blood Cancer"},{"key":"2021043017510027900_CIT0026","doi-asserted-by":"crossref","first-page":"422","DOI":"10.15585\/mmwr.mm6914e4","article-title":"Coronavirus disease 2019 in children\u2014United States, February 12-April 2, 2020","volume":"69","author":"Bialek","year":"2020","journal-title":"MMWR Morbidity Mortal Wkly Rep"},{"key":"2021043017510027900_CIT0027","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1056\/NEJMc2005073","article-title":"SARS-CoV-2 infection in children","volume":"382","author":"Lu","year":"2020","journal-title":"N Engl J Med"},{"key":"2021043017510027900_CIT0028","doi-asserted-by":"crossref","DOI":"10.1101\/2020.07.09.20148429","article-title":"Longitudinal evaluation and decline of antibody responses in SARS-CoV-2 infection","volume-title":"medRxiv","author":"Seow","year":"2020"},{"key":"2021043017510027900_CIT0029","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research electronic data capture (REDCap)\u2013a metadata-driven methodology and workflow process for providing translational research informatics support","volume":"42","author":"Harris","year":"2009","journal-title":"J Biomed Inform"},{"key":"2021043017510027900_CIT0030","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/s41586-020-2196-x","article-title":"Virological assessment of hospitalized patients with COVID-2019","volume":"581","author":"W\u00f6lfel","year":"2020","journal-title":"Nature"},{"key":"2021043017510027900_CIT0031","article-title":"Neutralizing antibody responses to SARS-CoV-2 in a COVID-19 recovered patient cohort and their implications [Preprint]","author":"Wu","year":"2020","journal-title":"SSRN Electron J"},{"key":"2021043017510027900_CIT0032","author":"Allegheny County Health Department"},{"key":"2021043017510027900_CIT0033","doi-asserted-by":"crossref","first-page":"e1002331","DOI":"10.1371\/journal.ppat.1002331","article-title":"The SARS-coronavirus-host interactome: identification of cyclophilins as target for pan-coronavirus inhibitors","volume":"7","author":"Pfefferle","year":"2011","journal-title":"PLoS Pathog"}],"container-title":["Journal of the Pediatric Infectious Diseases Society"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jpids\/advance-article-pdf\/doi\/10.1093\/jpids\/piaa123\/34135181\/piaa123.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jpids\/article-pdf\/10\/4\/426\/37739973\/piaa123.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jpids\/article-pdf\/10\/4\/426\/37739973\/piaa123.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,9]],"date-time":"2023-10-09T09:56:39Z","timestamp":1696845399000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jpids\/article\/10\/4\/426\/5922694"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,13]]},"references-count":33,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2020,10,13]]},"published-print":{"date-parts":[[2021,4,30]]}},"URL":"https:\/\/doi.org\/10.1093\/jpids\/piaa123","relation":{},"ISSN":["2048-7207"],"issn-type":[{"value":"2048-7207","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,4,1]]},"published":{"date-parts":[[2020,10,13]]}}}